Established in 1980, Sichuan Xieli Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical enterprise from the cultivation of herbal plants to R&D and production of natural active ingredients and oncology APIs in China. There are three production bases span from China to Viet Nam, which includes two API and formulation production bases located in Pengzhou, Sichuan, and one plant extraction factory located in Vietnam. 

Xieli takes the leading role in the manufacture and supply of natural active pharmaceutical ingredients in the world. We passed cGMP inspections from international agencies such as US FDA, EDQM, MHRA and PMDA，and we are the qualified supplier for multiple “Fortune 500” drug manufacturer giants. The export volume of our key products ranks first in China and they are exported to 50 countries and regions including the European Union, Eastern Europe, South America, Southeast Asia, etc. 

Chengdu Xinxiechuang Pharmatech, one subsidiary of Xieli Pharma group, is mainly engaged in the R&D and scale-up manufacture of new and existing products before GMP production and other quality-related studies (CRO). Together with our mother company, we are striving to be one-stop out-sourcing provider to our global clients from early development stages to commercial GMP production.